Company Filing History:
2 out of 110 
2 out of 16 Years Active: 2017-2020
Title: Innovations by Arihiro Aihara
Introduction
Arihiro Aihara is a notable inventor based in Providence, Rhode Island. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of two patents to his name, Aihara's work focuses on the modulation of beta-hydroxylase activity, which plays a crucial role in cell proliferation disorders.
Latest Patents
Aihara's latest patents include inhibitors of beta-hydroxylase for the treatment of cancer. These inventions relate to compounds that modulate the activity of beta-hydroxylase, specifically Asparatyl (asparaginyl) beta-hydroxylase (ASPH). The patents detail novel 2-aryl-5-amino-3(2H)-furanone and 2-heteroaryl-5-amino-3(2H)-furanone compounds. They also encompass pharmaceutical compositions, methods for synthesis, and applications of these compounds in both cell-free samples and cell-based assays. Furthermore, the inventions aim to ameliorate or treat cell proliferation disorders.
Career Highlights
Arihiro Aihara has worked with prominent institutions such as Rhode Island Hospital and Midwestern University. His experience in these organizations has contributed to his expertise in the field of cancer research and drug development.
Collaborations
Some of Aihara's notable coworkers include Jack Raymond Wands and Suzanne M De La Monte. Their collaborative efforts have likely enhanced the research and development processes in which Aihara has been involved.
Conclusion
Arihiro Aihara's innovative work in developing inhibitors of beta-hydroxylase showcases his commitment to advancing cancer treatment. His contributions through patents and collaborations highlight the importance of research in addressing critical health challenges.